Xtant Medical 

$0.57
0
-$0.01-2.12% Monday 00:02

統計

當日最高
0.57
當日最低
0.57
52週高點
-
52週低點
-
成交量
9
平均成交量
-
市值
80.18M
本益比
-
股息殖利率
-
股息
-

即將到來

財報

30Apr預期
Q3 2025
下一步
-0.01
-0
0
0.01
預期EPS
-0.01015
實際EPS
不適用

財務

-14.03%利潤率
未盈利
2019
2020
2021
2022
2023
2024
234.53M營收
-32.9M淨利

分析師評級

$1.00平均目標價
最高預估為 1.00。
來自過去6個月內的 1 則評分。這不是投資建議。
買入
100%
持有
0%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 XTNT.BOATS 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The company offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, which can be compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, the company offers cervical products comprising Spider cervical plating, Streamline OCT, and CervAlign systems; thoracolumbar products consisting of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; and Silex sacroiliac joint fusion systems. Further, it provides interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
Show more...
執行長
Mr. Sean E. Browne
員工
217
國家
US
ISIN
US98420P3082

上市

0 Comments

分享你的想法

FAQ

Xtant Medical 今天的股價是多少?
XTNT.BOATS 目前價格為 $0.57 USD,過去 24 小時下跌了 -2.12%。在圖表上更密切關注 Xtant Medical 股票的表現。
Xtant Medical 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Xtant Medical 的股票以代號 XTNT.BOATS 進行交易。
Xtant Medical 的市值是多少?
今天 Xtant Medical 的市值為 80.18M
Xtant Medical 下一次財報日期是什麼時候?
Xtant Medical 將於 April 30, 2026 公布下一次財報。
Xtant Medical 上一季度的財報如何?
XTNT.BOATS 上一季度的財報為每股 0.01 USD,預估為 -0.01 USD,帶來 +278.1% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Xtant Medical 去年的營收是多少?
Xtant Medical 去年的營收為 234.53MUSD。
Xtant Medical 去年的淨利是多少?
XTNT.BOATS 去年的淨收益為 -32.9MUSD。
Xtant Medical 有多少名員工?
截至 April 01, 2026,公司共有 217 名員工。
Xtant Medical 位於哪個產業?
Xtant Medical從事於Health Care產業。
Xtant Medical 何時完成拆股?
Xtant Medical 最近沒有進行任何拆股。
Xtant Medical 的總部在哪裡?
Xtant Medical 的總部位於 US 的 Belgrade。